TMC Life Sciences BhdXKLS:0101 +1.11%62 PEG Ratio is 5.81 as of Jul. 06, 2026, which is 102% above its 10-year median of 2.88. GuruFocus rates XKLS:0101 with a GF Score™ of 62/100 and a GF Value™ of RM0.62 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 225 Healthcare Providers & Services companies, TMC Life Sciences Bhd ranks worse than 84.44% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for TMC Life Sciences Bhd's PEG Ratio or its related term are showing as below:
XKLS:0101'
s PEG Ratio Range Over the Past 10 Years
Min: 0.07 Med: 2.88 Max: 27.99
Current: 5.81
During the past 13 years, TMC Life Sciences Bhd's highest PEG Ratio was 27.99. The lowest was 0.07. And the median was 2.88.
XKLS:0101's PEG Ratio is ranked worse than 84.44% of 225
companies
in the Healthcare Providers & Services industry
Industry Median: 1.41
vs XKLS:0101: 5.81
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
TMC Life Sciences Bhd (XKLS:0101) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TMC Life Sciences Bhd PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's PEG Ratio distribution charts can be found below:
* The bar in red indicates where TMC Life Sciences Bhd's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
TMC Life Sciences Bhd (XKLS:0101) has a PEG Ratio of 5.81 as of Jul. 06, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on TMC Life Sciences Bhd and its competitors. This is 102% above median its historical median of 2.88. Over the past decade, TMC Life Sciences Bhd's PEG Ratio has ranged from 0.07 to 27.99. According to the industry distribution chart, TMC Life Sciences Bhd ranks #190 out of 225 companies in the Healthcare Providers & Services industry, placing it in the top 84.4%.
Is TMC Life Sciences Bhd's PEG Ratio too high?
TMC Life Sciences Bhd's current PEG Ratio of 5.81 is 102% above median its 10-year median of 2.88. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 27.99. The Healthcare Providers & Services industry median PEG Ratio is 1.41. TMC Life Sciences Bhd's value of 5.81 is 312.1% above this industry median. Based on the distribution chart, TMC Life Sciences Bhd ranks #190 out of 225 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, TMC Life Sciences Bhd has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's PEG Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, TMC Life Sciences Bhd ranks #190 out of 225 companies for PEG Ratio. This places TMC Life Sciences Bhd in the lower half of its industry. The industry median PEG Ratio is 1.41. TMC Life Sciences Bhd's value of 5.81 is 312.1% above this benchmark. Historically, TMC Life Sciences Bhd's own PEG Ratio has ranged from 0.07 to 27.99 over the past decade. While the company's 10-year median is 2.88 vs. the industry median of 1.41, TMC Life Sciences Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.41, based on 225 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TMC Life Sciences Bhd's current PEG Ratio of 5.81 is 312.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on TMC Life Sciences Bhd and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMC Life Sciences Bhd's current PEG Ratio is 5.81, which is 102% above median its own 10-year median of 2.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.62, compared to a current price of RM0.46 — trading 26.6% below its estimated fair value. The current PEG Ratio is 5.81, which is 102% above median its 10-year median of 2.88 and 312.1% above the Healthcare Providers & Services industry median of 1.41. TMC Life Sciences Bhd's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current PEG Ratio is 5.81 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?
Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued.
The current stock price of RM0.46 is trading 26.6% below its estimated GF Value™ of RM0.62.
GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0101:
PEG Ratio: 5.81 (102% above median its 10-year median of 2.88)
GF Value™: RM0.62 vs. price of RM0.46 (26.6% below fair value)
Industry Position: 312.1% above the Healthcare Providers & Services median (#190 of 225)
No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
62GF Score
Get the complete analysis for XKLS:0101
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0101 has been successfully added to your 
